Skip to main content
. 2020 Mar 26;11:272. doi: 10.3389/fphar.2020.00272

Figure 4.

Figure 4

hAFMSCs upregulated the expression level of hGC markers in OPA disease, (A) hAFMSCs increased the number of FSHR+AMH+ positive hGCs. (B) hAFMSCs increased the number of FOXL2+CYP19A1+ positive hGCs. (C) hAFMSCs increased the protein level of hGC markers (FSHR, AMH, FOXL2, and CYP19A1). The error bars indicate the SD; **, p < 0.01; ***, p < 0.001; (compared with the OPA group).